Marie Do, MD

Transfusion Medicine

Marie Do, MD Clinical/Adjunct Assistant Professor

Department: Pathology

Phone: (804) 828-0093

Fax: (804) 828-0876

Marie Christine Do, MD, MMSC, (MedED), has been an attending physician in the Department of Clinical Pathology since 2007. She earned her undergraduate degree from the University of Virginia in 2000, and her M.D. from the VCU School of Medicine in 2004. She completed her training in Clinical Pathology at VCU in 2007.

In 2023, she completed a Master’s in Medical Sciences in Medical Education at Harvard Medical School.

Her current interests include Medical Education (Graduate and Undergraduate), Gamification, Transfusion Medicine, and Apheresis.

Clinical Specialties/Research Interests: Clinical Pathology, Medical Education

Contact Dr. Do for a full CV

Print/Download Dr. Do Web CV (pdf)

Dr. Marie Do abbreviated CV

Education

Postgraduate Medical Training

2023 Fellowship, Genitourinary Pathology, University of Michigan, Michigan Medicine, Ann Arbor, MI
2023 Fellowship, Surgical Pathology, University of Michigan, Michigan Medicine, Ann Arbor, MI

2022 Residency, Anatomic Pathology, National Institutes of Health, National Cancer Institute, Bethesda, MD

Medical Education

2013 Bachelor of Medicine, Bachelor of Surgery, B.P. Koirala Institute of Health Sciences, Sunsari, Nepal

Licenses & Certifications

Michigan Board of Medicine, Physician license

Controlled Substance license

Anatomic and Clinical Pathology, American Board of Pathology

Selected Publications

Peer Reviewed Papers

Relan, A.; Desar, S.; Dunnette, B.; Shanley, R. & Giubellino, A. Inflammatory infiltrates in melanocytic lesions. Int. J.Morphol., 39(2):512‐519, 2021.

Huang N, Perez P, Kato T, Mikami Y, Okuda K, Gilmore R, Conde C, Gasmi B, Stein S, Beach M, Pelayo E, Maldonado J, Lafont B, Padilla N, Murrah V, Maile R, Sampaio De Melo M, Dikoglu E, Desar S, Ylaya K, Chung JY, Smith G, Vannella K, Kleiner D, Chertow D, Richert M, Nasir N, Das S, Lee R, Warner B. SARS‐CoV‐2 infection of the oral cavity and saliva. Accepted for publication in nature medicine. Manuscript # NMED‐A109277C.

Song K, Desar S, Pengo T, Shanley R, Giubellino A. Correlation of MET and PDL1 expression in Malignant Melanoma. Cancers (Basel). 2020;12(7):E1847. Published 2020 Jul 9. doi:10.3390/cancers12071847.

Diggs LP, Ruf B, Ma C, Heinrich B, Cui L, Zhang Qianfei, McVey J, Wabitsch S, Heinrich S, Rosato U, Lai W, Subramanyam V, Longerich T, Loosen SH, Luedde T, Neumann UP, Desar S, Kleiner D, Gores G, Wang XW, Greten TF. CD40‐mediated immune cell activation enhances response to anti‐PD‐1 in murine intrahepatic cholangiocarcinoma. J Hepatol . 2020 Dec 1; S0168‐8278(20)33824‐1. doi: 10.1016/j.jhep.2020.11.037.

Abstracts/Meeting Presentations

Desar S, Cowen E, Lee CC, Merino MM. “Clinical, Morphologic and Molecular Characteristics of Cutaneous Leiomyomas, a Tool to Recognize Hereditary Leiomyomatosis and Renal Cell Cancer”. USCAP 111th Annual Meeting, 2022, Platform Presentation Dermatopathology.

Desar S, Giubellino A, Lee CC. “Report of a new Family with BAP1 Cancer Syndrome and Review of the Literature”. American Society of Dermatopathology, 2020, dual presentation.

Desar S, Sargen M, Cowen EW, Lee CC, “Intradermal nevus with extensive neurotization and neurofibroma‐like changes in a patient with BAP‐1 Tumor Predisposition Syndrome.” American Society of Dermatopathology, 2021, Poster Session 2, #251.

Chapter
“Blue nevus/Cellular Blue nevus” Pathology outlines. Ali Alani MD, Sabina Desar MD, Carlos Torres‐Cabala, MD.